A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002)
Status:
Terminated
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This study will define an effective starting dose for subcutaneous administration of MK2578
to correct anemia in erythropoiesis-stimulating agent (ESA)-naive patients with chronic
kidney disease (CKD) who are not on dialysis while evaluating its safety.